Blue7

Blue7 is a Singapore based impact investor. We directly support passionate entrepreneurs with bold and effective solutions that address underserved needs in livelihood resilience, community development and environmental protection. We also invest in global impact funds as well as ESG scored listed equities. ​Blue7 deploys a variety of financial instruments ranging from debt to equity. Working with partners in Asia and beyond, our portfolio operates to create long term value for society and the environment.

Juanita Fu

Co-Founder

MA Hui Hsing

Co-Founder

3 past transactions

AMILI

Series A in 2022
Developer of a gut microbiome therapy designed to advance microbiome research to address unmet and critical needs in healthcare. The company collects gut microbiome stools that will be used to advance microbiome research and treatment which will potentially save the lives of patients suffering from infections and other diseases and has also developed a test aiming to identify the types of gut microbiota, enabling medical professionals to advance human health through microbe science.

Smarter Health

Series A in 2022
Smarter Health is an online healthcare platform that facilitates connections between patients and quality specialist care worldwide. The platform enables users to find and book appointments with specialist doctors who can address specific medical conditions and provide accurate diagnoses. Patients can compare and select professionals based on their recommended treatment plans, profiles, and estimated treatment costs. By offering a streamlined process for accessing specialist care, Smarter Health aims to enhance care plans and improve patients' quality of life while maintaining affordability.

Pintek

Series A in 2021
Pintek is a financial technology company aiming to democratise access to education in Indonesia through affordable and flexible credit.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.